[(186/188)Re] rhenium-ethylene dicysteine (Re-Ec): Preparation and evaluation for possible use in endovascular brachytherapy

Nuclear Medicine and Biology

Volumn 27, Issue 2, 2000, Pages 189-197

  Das, Tapas ^a   Banerjee, Sharmila ^a   Samuel, Grace ^a   Kothari, Kanchan ^a   Unni, P R ^a   Sarma, H D ^a   Ramamoorthy, N ^a   Pillai, M R A ^a  

^a BHABHA ATOMIC RESEARCH CENTRE   (India)

Author keywords

Endovascular brachytherapy; Ethylene dicysteine; Restenosis; Rhenium

Indexed keywords

CYSTINE; ETHYLENE DICYSTEINE; RADIOPHARMACEUTICAL AGENT; RHENIUM COMPLEX; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BRACHYTHERAPY; COMPLEX FORMATION; CONTROLLED STUDY; CORONARY ARTERY DILATATION; NONHUMAN; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; RADIOISOTOPE DISTRIBUTION; RAT; RESTENOSIS; THIN LAYER CHROMATOGRAPHY;

ANIMALS; BRACHYTHERAPY; CHROMATOGRAPHY, THIN LAYER; CYSTEINE; ELECTROPHORESIS, PAPER; HYDROGEN-ION CONCENTRATION; ISOTOPE LABELING; MICE; ORGANOTECHNETIUM COMPOUNDS; RADIOISOTOPES; RADIOPHARMACEUTICALS; RATS; RATS, WISTAR; RHENIUM; TISSUE DISTRIBUTION;

EID: 0034037943     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-8051(99)00097-9     Document Type: Article

References (16)

1. Bittl J. Advances in coronary angioplasty. N. Engl. J. Med. 335:1996;1290-1302.
2. Blondeau P., Berse C., Gravel D. Dimerization of an intermediate during the sodium in liquid ammonia reduction of L-thiazolidine-4-carboxylic acid. Can. J. Chem. 45:1967;49-52.
3. Deutsch E., Libson K., Vanderheyden J.L., Ketring A.R., Maxon H.R. The chemistry of rhenium and technetium as related to the use of isotope of these elements in therapeutic and diagnostic nuclear medicine. Nucl. Med. Biol. 13:1986;465-477.
4. 99mTc renal tubular function agents Current status . Semin. Nucl. Med. 20:1990;28-40.
5. Hafeli U.O., Lee E.J., Ciezki J., Gayle J.P., Martin B.S., Weinhous M.S. Suitability of beta-emitting rhenium for inhibiting restenosis in coronary arteries. J. Brachytherapy Intl. 15:1999;1-11.
6. 188Re generator. Appl. Radiat. Isot. 45:1994;1123-1128.
7. Knapp F. F. Jr., Guhlke S., Beets A. L., Amols H. and Weinberger J. (1997) Intraarterial irradiation with rhenium-188 for inhibition of restenosis by PTCA - Strategy and evaluation of species for rapid urinary excretion (abstract). J. Nucl. Med. 38, 124P.
8. 186Re]Re-HEDP. Appl. Radiat. Isot. 51:1999;51-58.
9. Lee J., Choi Y. J., Lee D. S., Shin S. A., Chung J. K., Lee M. M. and Lee M. C. (1999) Rhenium-188-DTPA liquid-filled balloon to inhibit restenosis after angioplasty: Development of software of dose calculation and application (abstract). J. Nucl. Med. 40, 181P.
10. Oh S. J., Moon D. H., Park S. W., Hong M. K., Park S. J., Shin J. W., Shin S. K., Kim E. H., Lim S. M., Choi C. W., Choi T. H. and Lee H. K. (1999) Comparison of radiation absorbed dose of Re-188 radiopharmaceuticals for intracoronary radiation therapy in case of balloon rupture (abstract). J. Nucl. Med. 40, 41P.
11. Oh S. J., Moon D. H., Park S. W., Lee B. Y., Hong M. K., Park S. J., Kim E. H., Lim S. M., Choi C. W., Choi T. H. and Lee H. K. (1999) Radiation dosimetry of a balloon filled with rhenum-188 and ionic contrast for endovascular radiation therapy (abstract). J. Nucl. Med. 40, 309P.
12. Verbruggen A.M., Nosco D.L., Vannerom C.G., Bormans G.M., Adriaens P.J., De Roo M. J. Technetium-99m-L,L,-ethylene dicysteine - A renal imaging agent. 1. Labeling and evaluation in animals. J. Nucl. Med. 33:1992;551-557.
13. Waksman R. Clinical trials in radiation therapy. Vascular Brachytherapy Monitor. 1:1998;10-18.
14. Waksman R., Crocker I.A., Kikeri D. Endovascular low dose radiation for prevention of restenosis following angioplasty for treatment of narrowed dialysis arterio-venous grafts. J. Am. Coll. Cardiol. 27:1996;214A.
15. 3: A potential therapeutic agent for prevention of restenosis after CTPA (abstract). J. Nucl. Med. 40, 152P.
16. Weinberger J. and Knapp F. F. (1999) Use of liquid-filled balloons for coronary irradiation. In: Vascular Brachytherapy, 2nd ed. (Edited by Waksman R.), pp. 521-535. Futura Publishing Co., Inc., Armonk, NY.